Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings ... for the broad commercial launch of the Z1™ Femoral Hip System (Z1 System) for total hip arthroplasty at the 2024 annual meeting of ...

Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

Citi opened a “90-day positive catalyst watch” on shares of Zimmer Biomet (ZBH) while keeping a Neutral rating on the name with a $120 price ...

In 2024, several spine and orthopedic medtech companies banded together through mergers and acquisitions. 1. Enovis completed its acquisition of LimaCorporate in January. LimaCorporate will add to ...

Zimmer Biomet Holdings ... the company announced plans for the commercial launch of the Z1 Femoral Hip System (Z1 System) for total hip arthroplasty at the 2024 annual American Association ...

Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who ...

Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray ...

(RTTNews) - Zimmer Biomet (ZBH) announced FDA 510(k) clearance for the OsseoFit Stemless Shoulder System for total shoulder replacement. The company said this implant is designed to match the natural ...

Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings ... of Persona ® SoluTion™ Porous Plasma Spray (PPS ®) Femur, a total knee implant component offering an alternative for patients with ...

Zimmer Biomet has secured the US Food and Drug Administration (FDA) 510(k) clearance for its total knee implant component, Persona SoluTion porous plasma spray (PPS) femur. It provides an ...